HomeCompareSHMUY vs JNJ

SHMUY vs JNJ: Dividend Comparison 2026

SHMUY yields 1.24% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $10.3K in total portfolio value· pulled ahead in Year 5
10 years
SHMUY
SHMUY
● Live price
1.24%
Share price
$91.30
Annual div
$1.13
5Y div CAGR
-41.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$0.59
Full SHMUY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SHMUY vs JNJ

📍 JNJ pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHMUYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHMUY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHMUY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHMUY
Annual income on $10K today (after 15% tax)
$105.20/yr
After 10yr DRIP, annual income (after tax)
$0.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,985.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHMUY + JNJ for your $10,000?

SHMUY: 50%JNJ: 50%
100% JNJ50/50100% SHMUY
Portfolio after 10yr
$25.1K
Annual income
$2,344.99/yr
Blended yield
9.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SHMUY
No analyst data
Altman Z
2.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHMUY buys
0
JNJ buys
0
No recent congressional trades found for SHMUY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHMUYJNJ
Forward yield1.24%2.13%
Annual dividend / share$1.13$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-41.5%28%
Portfolio after 10y$20.0K$30.3K
Annual income after 10y$0.59$4,689.40
Total dividends collected$175.00$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHMUY vs JNJ ($10,000, DRIP)

YearSHMUY PortfolioSHMUY Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,772$72.40$10,592$272.30+$180.00SHMUY
2$11,569$42.64$11,289$357.73+$280.00SHMUY
3$12,404$25.04$12,123$472.89+$281.00SHMUY
4$13,287$14.68$13,141$629.86+$146.00SHMUY
5← crossover$14,226$8.60$14,408$846.81$182.00JNJ
6$15,226$5.03$16,021$1,151.60$795.00JNJ
7$16,295$2.94$18,122$1,588.22$1.8KJNJ
8$17,438$1.72$20,930$2,228.20$3.5KJNJ
9$18,659$1.01$24,792$3,191.91$6.1KJNJ
10$19,966$0.59$30,274$4,689.40$10.3KJNJ

SHMUY vs JNJ: Complete Analysis 2026

SHMUYStock

Shimizu Corporation engages in the building contracting, civil engineering, machinery, and other construction works in Japan. It is also involved in the research, planning, study, evaluation, diagnosis, soil analysis, surveying, design, supervision, management, and consultancy related to regional, urban, ocean, space, resources, and energy developments, as well as construction works and environment improvement; and purchase, sale, letting, brokerage, management, appraisal, and consultancy of real estate. The company constructs, lets, sells, and caretaking of residential houses and other buildings; plans, constructs, possesses, maintains, and operates public office buildings, roads, harbors, airports, and parks, as well as educational and cultural, medical and welfare, and water supply and sewerage facilities; generates and supplies electricity and heat; undertakes purification works; collects, disposes, and reutilizes waste; and designs, installs, leases, sells, and maintains information communication and building management system. It also engages in the cultivation of agricultural produce and seafood, and forestry work; maintenance and upkeep, security, and cleaning of buildings, equipment, and machinery; and design, manufacture, sale, lease, and brokerage of construction machinery and materials, concrete and wooden products, furniture, and interior fitting. The company offers industrial property, copyrights, and computer software; pharmaceutical, medical care material, and medical machinery and equipment; and advertisement, publication, printing, images and other information media, business event, inland transportation, warehouse, distribution center, insurance and travel agency, manpower supply, loan, guarantee, and factoring services. It also engages in the management and consultancy of sporting, hotel, restaurant, nursing, and resort facilities. The company was founded in 1804 and is headquartered in Tokyo, Japan.

Full SHMUY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SHMUY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHMUY vs SCHDSHMUY vs JEPISHMUY vs OSHMUY vs KOSHMUY vs MAINSHMUY vs ABBVSHMUY vs MRKSHMUY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.